Resultats de la cerca - Basu, Gargi

Successful Treatment of Advanced Metastatic Prostate Cancer following Chemotherapy Based on Molecular Profiling per Myers, Charles E., Basu, Gargi, Wright, Brian, Mahanes, Joanne, Spinelli, Anthony

Obtenir text complet Obtenir text complet Obtenir text complet

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells per Basu, Gargi D, Pathangey, Latha B, Tinder, Teresa L, Gendler, Sandra J, Mukherjee, Pinku

Obtenir text complet Obtenir text complet Obtenir text complet

A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells per Basu, Gargi D, Liang, Winnie S, Stephan, Dietrich A, Wegener, Lee T, Conley, Christopher R, Pockaj, Barbara A, Mukherjee, Pinku

Obtenir text complet Obtenir text complet Obtenir text complet

Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases per Gatalica, Zoran, Millis, Sherri Z., Vranic, Semir, Bender, Ryan, Basu, Gargi D., Voss, Andreas, Von Hoff, Daniel D.

Obtenir text complet Obtenir text complet

MUC1 enhances tumor progression and contributes towards immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma per Tinder, Teresa L., Subramani, Durai B., Basu, Gargi D., Bradley, Judy M., Schettini, Jorge, Million, Arefayene, Skaar, Todd, Mukherjee, Pinku

Obtenir text complet Obtenir text complet

Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition() per Mukherjee, Pinku, Basu, Gargi D., Tinder, Teresa L., Subramani, Durai B., Bradley, Judy M., Arefayene, Million, Skaar, Todd, De Petris, Giovanni

Obtenir text complet Obtenir text complet

Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers per Wen, Wenhsiang, Chen, Wangjuh (Sting), Xiao, Nick, Bender, Ryan, Ghazalpour, Anatole, Tan, Zheng, Swensen, Jeffrey, Millis, Sherri Z., Basu, Gargi, Gatalica, Zoran, Press, Michael F.

Obtenir text complet Obtenir text complet Obtenir text complet

The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series per Drenner, Kevin, Basu, Gargi D., Goodman, Laurie J., Ozols, Audrey A., LoBello, Janine R., Royce, Thomas, Gordon, Michael S., Borazanci, Erkut H., Steinbach, Margaux A., Trent, Jeffrey, Sharma, Sunil

Obtenir text complet Obtenir text complet Obtenir text complet

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer per Azorsa, David O, Gonzales, Irma M, Basu, Gargi D, Choudhary, Ashish, Arora, Shilpi, Bisanz, Kristen M, Kiefer, Jeffrey A, Henderson, Meredith C, Trent, Jeffrey M, Von Hoff, Daniel D, Mousses, Spyro

Obtenir text complet Obtenir text complet Obtenir text complet

Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6 per Tiedemann, Rodger E., Zhu, Yuan Xiao, Schmidt, Jessica, Yin, Hongwei, Shi, Chang-Xin, Que, Qiang, Basu, Gargi, Azorsa, David, Perkins, Louise M., Braggio, Esteban, Fonseca, Rafael, Bergsagel, P. Leif, Mousses, Spyro, Stewart, A. Keith

Obtenir text complet Obtenir text complet Obtenir text complet

Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra(®) per White, Tracey, Szelinger, Szabolcs, LoBello, Janine, King, Amy, Aldrich, Jessica, Garinger, Nathan, Halbert, Matthew, Richholt, Ryan F., Mastrian, Stephen D., Babb, Cody, Ozols, Audrey A., Goodman, Laurie J., Basu, Gargi D., Royce, Thomas

Obtenir text complet Obtenir text complet Obtenir text complet

High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation per Azorsa, David O, Robeson, RiLee H, Frost, Danielle, hoovet, Bessie Meec, Brautigam, Gillian R, Dickey, Chad, Beaudry, Christian, Basu, Gargi D, Holz, David R, Hernandez, Joseph A, Bisanz, Kristen M, Gwinn, Leslie, Grover, Andrew, Rogers, Joseph, Reiman, Eric M, Hutton, Michael, Stephan, Dietrich A, Mousses, Spyro, Dunckley, Travis

Obtenir text complet Obtenir text complet Obtenir text complet

Identifying treatment options for BRAF(V600) wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial per LoRusso, Patricia M., Sekulic, Aleksandar, Sosman, Jeffrey A., Liang, Winnie S., Carpten, John, Craig, David W., Solit, David B., Bryce, Alan H., Kiefer, Jeffrey A., Aldrich, Jessica, Nasser, Sara, Halperin, Rebecca, Byron, Sara A., Pilat, Mary Jo, Boerner, Scott A., Durecki, Diane, Hendricks, William P. D., Enriquez, Daniel, Izatt, Tyler, Keats, Jonathan, Legendre, Christophe, Markovic, Svetomir N., Weise, Amy, Naveed, Fatima, Schmidt, Jessica, Basu, Gargi D., Sekar, Shobana, Adkins, Jonathan, Tassone, Erica, Sivaprakasam, Karthigayini, Zismann, Victoria, Calvert, Valerie S., Petricoin, Emanuel F., Fecher, Leslie Anne, Lao, Christopher, Eder, J. Paul, Vogelzang, Nicholas J., Perlmutter, Jane, Gorman, Mark, Manica, Barbara, Fox, Lisa, Schork, Nicholas, Zelterman, Daniel, DeVeaux, Michelle, Joseph, Richard W., Cowey, C. Lance, Trent, Jeffrey M.

Obtenir text complet Obtenir text complet Obtenir text complet